In the midst of the ‘Me Too’ movement, a new study finds that people sexually harassed at work may be at increased risk for attempted suicide and suicide. The findings out of Sweden show that workplace sexual harassment may “represent an important risk factor for suicidal behavior,” said study author Linda Magnusson Hanson, an associate professor in the psychology department at Stockholm University, and colleagues. The research included more than 85,000 male and female workers in Sweden who completed a questionnaire between 1995 and 2013. It asked if they’d been sexually harassed at work in the past 12 months by either fellow workers, superiors or by what they termed “others,” such as clients, passengers, students or patients. Overall, nearly 5% of the workers reported workplace sexual harassment: about 2% of men and 7.5% of women. Those who said they were sexually harassed were more likely to be younger, single, divorced, in low-paid but high-strain jobs, and born outside of Europe. The workers were then followed for an average of up to 13 years. During that time, 125 died by suicide and 816 made a suicide attempt. While the study was only observational and did not prove a cause-and-effect link, workplace sexual harassment was associated with a nearly threefold increased risk of suicide and almost doubled increased risk of attempted suicide, the researchers found. The increased…  read on >

FRIDAY, Sept. 4, 2020 (Healthday News) — The chief adviser for the White House vaccine program said Thursday it was “extremely unlikely, but not impossible” that a vaccine could be available by the end of October. Speaking with National Public Radio, Dr. Moncef Slaoui said that the U.S. Centers for Disease Control and Prevention’s guidance to states to prepare for a vaccine as early as late October was “the right thing to do” in case a vaccine was ready by that time. “It would be irresponsible not to be ready if that was the case,” Slaoui said, adding that he first heard about the new CDC guidance from media reports, the Washington Post said. Still, Slaoui, the chief scientific adviser for Operation Warp Speed, described getting a vaccine by late October as a “very, very low chance.” That message ran counter to optimistic claims from the White House that a vaccine could be ready for distribution before the November presidential election. During the National Republican Convention, President Trump announced that a vaccine could be ready “before the end of the year or maybe even sooner.” Slaoui did confirm that the two main vaccine candidates, referred to as Vaccine A and Vaccine B by the CDC, were being developed by Pfizer and Moderna, respectively. He said there was “no intent” to introduce a vaccine before clinical…  read on >

With the arrival of late summer, it’s essential to know the signs of heat exhaustion and how to intervene before it escalates to a more severe condition like heat stroke, emergency medicine experts say. Heat exhaustion comes with symptoms including: heavy sweating; breathlessness; a fast, but weak, pulse; headache; dizziness; nausea or vomiting. “Heat exhaustion can happen to anyone overexerting themselves in extreme heat,” said Dr. Laura Burke, an emergency medicine physician at Beth Israel Deaconess Medical Center in Boston. “If symptoms are severe, call for medical help right away.” Some people have an increased risk of heat exhaustion, including: People with heart disease or high blood pressure. People over age 65. Infants and children. People with sunburn, which impairs the cooling mechanism of the skin. If heat exhaustion occurs and appropriate measures are not taken to cool down, it can sometimes escalate to a life-threatening condition called heat stroke. “During heat stroke, the body can no longer cool itself down through sweating, which can result in damage to major organs,” Burke said in a hospital news release. Symptoms of heat stroke include hot and dry skin, a fever higher than 102 degrees Fahrenheit, headache, confusion and unconsciousness. “If you see someone suffering from heat stroke, try to cool the person down by getting to shade or into the air conditioning. Apply cool water with…  read on >

It may seem like a paradox, but giving someone a gift to help them save money is a sure way to make them hate it. The reason: It will make the recipient feel inferior to you, researchers say. In contrast, a gift that helps a recipient save time is taken as a compliment. The findings, from a series of experiments, are outlined in a study recently published in the Journal of the Association for Consumer Research. “Most of us have this belief that any gift we give is going to be appreciated — but the way a gift is presented can influence how people feel about it,” said study co-author Grant Donnelly, assistant professor of marketing at Ohio State University, in Columbus. “When you don’t have time, you’re perceived as busy and in high demand. There’s something high-status about that, compared to not having enough money, which is seen as low status,” Donnelly said in a university news release. In one experiment, the researchers asked 405 people how they felt about receiving a gift they thought was intended to save them either time or money. Those who received a gift that was intended to save them money were more likely to say it made them feel embarrassed, ashamed and bad, compared to those who received a time-saving gift. “They thought the gift-giver was implying they…  read on >

It may seem like a paradox, but giving someone a gift to help them save money is a sure way to make them hate it. The reason: It will make the recipient feel inferior to you, researchers say. In contrast, a gift that helps a recipient save time is taken as a compliment. The findings, from a series of experiments, are outlined in a study recently published in the Journal of the Association for Consumer Research. “Most of us have this belief that any gift we give is going to be appreciated — but the way a gift is presented can influence how people feel about it,” said study co-author Grant Donnelly, assistant professor of marketing at Ohio State University, in Columbus. “When you don’t have time, you’re perceived as busy and in high demand. There’s something high-status about that, compared to not having enough money, which is seen as low status,” Donnelly said in a university news release. In one experiment, the researchers asked 405 people how they felt about receiving a gift they thought was intended to save them either time or money. Those who received a gift that was intended to save them money were more likely to say it made them feel embarrassed, ashamed and bad, compared to those who received a time-saving gift. “They thought the gift-giver was implying they…  read on >

As the World Health Organization cautioned on Monday that using plasma from COVID-19 survivors to treat other patients is still an experimental therapy, American scientists challenged a key statistic cited by U.S. officials as grounds for emergency approval of the treatment. In announcing the approval on Sunday, President Donald Trump and two of his top health officials spoke of the same stunning statistic — that the treatment had reduced deaths by 35 percent, the New York Times reported. Dr. Stephen Hahn, the commissioner of the Food and Drug Administration, went so far as to say that 35 out of 100 COVID-19 patients “would have been saved because of the administration of plasma.” But many scientists, including a researcher on the Mayo Clinic study from which the statistic was supposedly gleaned, said Monday they could not ascertain where the number came from and that Hahn had appeared to overstate the treatment’s benefits, the Times reported. “Do I know where the 35 percent comes from?” said Dr. Arturo Casadevall, one of the May Clinic study’s main authors who hails from Johns Hopkins University in Baltimore. “No.” The actual data from the Mayo Clinic study shows that, among a group of more than 35,000 patients, when plasma was given within three day of diagnosis, the death rate was about 22 percent, compared with 27 percent when it was…  read on >

If you have hypertension and you’re depressed, don’t blame your blood pressure drugs. Although previous research hinted there might be a connection between high blood pressure medications and depression, a new study of dozens of commonly used drugs found no such link. In fact, the Danish researchers found the opposite — nine blood pressure drugs were associated with a lower risk of depression. How could blood pressure medication help depression? “It is possible that the mechanism involved in decreasing the risk of depression is the anti-inflammatory effect among these nine medications,” study author Dr. Lars Vedel Kessing said in a statement from the journal Hypertension, where the findings were published Aug. 24. He’s a professor of psychiatry at the Psychiatric Center Copenhagen and the University of Copenhagen in Denmark. Kessing added that more study is needed. But the findings might help doctors when choosing medications to treat high blood pressure in patients who also have depression or a high risk of depression. He also noted that the study wasn’t designed to prove a cause-and-effect relationship between the medications and a lower risk of depression. The new study relied on a Danish population registry. The researchers included 5.4 million people in Denmark in 2005 and followed their health outcomes until December 2015. During that time, nearly 3.75 million people were given a prescription for a high…  read on >

Smokers with the most common type of heart rhythm disorder can reduce their risk of stroke and death by giving up cigarettes, a new study says. “Smoking precipitates blood clots that could lead to a stroke, which may be why giving up lowers risk,” said study author So-Ryoung Lee of Seoul National University Hospital in South Korea. But even former smokers had higher odds for stroke compared to never smokers, the study found. “The remaining stroke risk after quitting might be through the damage already caused to the arteries — called atherosclerosis,” Lee said in a European Society of Cardiology news release. Stroke is the most common cause of death in people with atrial fibrillation (a-fib). People with a-fib are five times more likely to have a stroke than those without the heart rhythm disorder. And a-fib increases the risk of death two-fold in women and 1.5-fold in men. Previous research has shown that smokers are at higher risk for a-fib and a subsequent stroke. This study included nearly 98,000 people, average age 61, in South Korea who were diagnosed with a-fib from 2010 to 2016. They were followed until the end of 2017, for a median follow-up of three years. Compared to current smokers, quitters were 30% less likely to have a stroke and 16% less likely to die from any cause. However, quitters…  read on >

Just weeks after colleges across the United States reopened their campuses for the fall semester, thousands of coronavirus infections are cropping up in students and staff alike. More than 1,500 American colleges and universities were tallied in The New York Times survey. That included every four-year public institution, every private college that competes in NCAA sports and others that identified cases. The case total: At least 26,000 cases and 64 deaths have been reported since the pandemic began, the Times reported. The trend is unfolding everywhere. The University of North Carolina at Chapel Hill sent most undergraduates home after COVID-19 clusters popped up in campus housing. In-person classes were delayed at Notre Dame as students tested positive by the hundreds. Clemson, Baylor, Louisville and dozens of other Division I universities have confirmed COVID-19 cases in their athletic departments. Meanwhile, aggressive testing of students moving into dorms turned up scores of cases at Iowa State, the Times reported. Meanwhile, the potential of convalescent plasma as a treatment for severe COVID-19 was still unclear Tuesday, as the World Health Organization cautioned the therapy remains experimental and American scientists challenged a key statistic cited by U.S. officials as grounds for emergency approval of the treatment. In announcing the approval this week, President Donald Trump and two of his top health officials stirred controversy when they used the same…  read on >

Despite the wave of criticism that has followed the U.S. Food and Drug Administration’s emergency approval of convalescent plasma to treat COVID-19 patients, infectious disease experts say the therapy remains promising. Some scientists have questioned both the timing of the approval and the veracity of a key survival statistic cited by FDA Commissioner Dr. Stephen Hahn. And the clinical trials needed to make sure that convalescent plasma really works are not yet complete. Still, survivors’ plasma has been on the list of potential COVID-19 treatments since the pandemic began and an emergency approval for its widespread use was not unexpected, said Dr. Liise-anne Pirofski, chair of biomedical research at the Albert Einstein College of Medicine and Montefiore Medical Center, in New York City. Data coming in from around the world shows that antibody-loaded plasma taken from COVID-19 survivors can help people fighting off an infection, Pirofski said. For example, reports from China have shown that desperately ill patients treated late in their disease with convalescent plasma experienced a very rapid decrease in their viral load, Pirofski noted. There’s also no evidence that convalescent plasma can hurt a person, she added. “I cannot think of one shred of data that I have seen that would suggest harm,” Pirofski said. But scientists still don’t know exactly how effective plasma can be, when it would be best administered…  read on >